The In Vitro Toxicity Testing Market, estimated at USD 10.04 Bn in 2025, is expected to exhibit a CAGR of 13.5% and reach USD 24.36 Bn by 2032.
The market growth is driven by rising demand for accurate and early disease detection, supported by advances in molecular diagnostics, imaging, and point-of-care testing. Growing focus on personalized medicine, supportive healthcare policies, and ongoing R&D investments are creating new opportunities for industry players.
increasing research and development activities by the research institutes in the market is expected to drive the market growth over the forecast period. For instance, in an article published on September 17, 2025, in the peer-reviewed journal Environment International, Lisa Zimmermann and colleagues from the Goethe University Frankfurt am Main, Germany, and Norwegian University of Science and Technology, Trondheim, Norway, revealed that two-thirds (67%) of the samples caused adverse reactions when tested for in vitro toxicity and chemical composition of extracts from bioplastics and plant-based materials used in food contact baseline toxicity, 42% oxidative stress, 23 % antiandrogenicity and one sample estrogenicity.” The single estrogenic sample was a Polylactic Acid (PLA) film.
Global In Vitro Toxicity Testing Market– Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdowns in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.There were three main ways that COVID-19 influenced the economy: directly by impacting supply and demand, indirectly by disrupting distribution networks, and economically by having an effect on businesses and financial markets.
Though COVID-19 pandemic had positive impact on global in vitro toxicity testing market owing to increasing adoption of invitro toxicity assessment test. For instance, an article published by National Center for Biotechnology Information (NCBI), on December 24, 2025, stated that since Since the COVID-19 outbreak, there has been more attention paid to how environmental factors impact an organism's immune system since they may combine with viruses to damage that organism's defences. Immunotoxicity is considered in environmental risk assessments because it has the potential to be the first sign of other toxic consequences because the immune system is more susceptible to it. The immunotoxicity test for environmental contaminants faces more difficulties than other toxicity endpoints such as genotoxicity, endocrine toxicity, or developmental toxicity, as a result of lack of comprehensive mechanisms of action and trustworthy testing techniques.
Global In Vitro Toxicity Testing Market : Key Development
On March 13, 2025, Charles River Laboratories International, Inc., a pharmaceutical company has launched Apollo, an cloud-based platform for drug developers that provides access to study data, study milestones, documents, cost estimates, and program planning tools to save time and enhance the client experience. The platform’s current capabilities are designed to support clients with safety assessment and toxicology studies.
On November 28, 2025, L'Oréal group, a cosmetics manufacturing company, attended the the The European Society of Toxicology In Vitro (ESTIV). The group presented their latest advances on the development of alternative methods through 11 posters, 2 podiums talks and 2 workshops. The conference's motto was "Sense of Purpose" for beauty without animal testing, which supports the cosmetic industry's use of in vitro toxicity testing.
Browse 45 Market Data Tables and 47 Figures spread through 170 Pages and in-depth TOC on “Global In Vitro Toxicity Testing Market ”- Forecast to 2032 By Type (Absorption, Toxic Substances, and Dose), By End User (Cosmetics Industry, Pharmaceutical Industry, Food Industry, and Chemicals Industry), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/in-vitro-toxicity-testing-market-3855
Key Takeaways of the Global In Vitro Toxicity Testing Market :
- The Global In Vitro Toxicity Testing Market is expected to exhibit a CAGR of 13.5% during the forecast period owing to increasing research and development activities in the market. For instance, on June 16, 2025, InSphero AG, a provider of 3D cell-based assay technology, established a pre-competitive consortium with representatives from pharmaceutical firms involved in the creation of cross-species drug testing and validation strategies for quick and accurate drug testing of drug-induced liver injury (DILI) and translation to humans.
- Major players operating in the global in vitro toxicity testing market include Bio-Rad Laboratories, Inc., Cyprotex, Covance Inc., LifeNet Health LifeSciences , Creative Bioarray, Charles River Laboratories, Intertek Group plc, LGC Limited, SGS Société Générale de Surveillance SA, Preferred Cell Systems, Microbac Laboratories, Inc., Eurofins Discovery, Creative Biolabs, LAUS GmbH, and Vimta Labs Ltd.
Contact Us